(CSPX) iShares Core SP500 USD EUR - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Etf •
ISIN: IE00B5BMR087
Large-Cap, Mid-Cap, US, Equities, Accumulating
Description: CSPX iShares Core SP500 USD EUR
The iShares Core S&P 500 UCITS ETF (USD Acc) ( ticker CSPX ) is a Netherlands-registered exchange-traded fund that tracks the Morningstar US Large-Mid NR USD index, effectively replicating the performance of the S&P 500 total-return series.
Key characteristics:
- Asset class: US Large-Cap Blend Equity
- Structure: physically replicated, accumulating (dividends are reinvested rather than paid out)
- Expense ratio: 0.07 % per annum (one of the lowest in the market, enhancing net returns over the long run)
Recent quantitative signals (as of Q3 2024):
- Weighted average market-cap of the holdings ≈ $150 bn, indicating exposure to the mega-cap tier of the S&P 500.
- Sector weighting is heavily tilted toward Information Technology (≈ 27 % of assets) and Health Care (≈ 13 %), both of which have shown earnings growth rates above the index average in the past 12 months.
- Liquidity metric: average daily trading volume exceeds €200 m, resulting in a bid-ask spread typically below 0.5 bps, which minimizes transaction costs for large investors.
Macro-driven considerations:
- US monetary policy remains a primary driver; the Federal Reserve’s stance on interest rates directly influences equity valuations, especially for growth-heavy sectors like tech.
- Corporate earnings resilience in the face of a moderate slowdown in consumer spending supports the fund’s defensive tilt.
- Fiscal policy uncertainty (e.g., potential tax reforms) could alter after-tax cash-flow expectations for the underlying constituents.
Given its low cost, broad market exposure, and high liquidity, CSPX is a strong candidate for a core long-term equity holding, provided investors are comfortable with the inherent US market risk.
For a deeper dive into the fund’s risk-adjusted performance and scenario analysis, you might explore the ValueRay platform, which offers granular, data-driven tools to stress-test such exposures.
CSPX ETF Overview
Market Cap in USD | 153,951m |
Category | US Large-Cap Blend Equity |
TER | 0.07% |
IPO / Inception | 2010-05-19 |
CSPX ETF Ratings
Growth Rating | 53.6% |
Fundamental | - |
Dividend Rating | - |
Return 12m vs S&P 500 | -5.62% |
Analyst Rating | - |
CSPX Dividends
Currently no dividends paidCSPX Growth Ratios
Growth Correlation 3m | 91.4% |
Growth Correlation 12m | -15.7% |
Growth Correlation 5y | 91.6% |
CAGR 5y | 16.20% |
CAGR/Max DD 3y (Calmar Ratio) | 0.69 |
CAGR/Mean DD 3y (Pain Ratio) | 4.83 |
Sharpe Ratio 12m | 0.78 |
Alpha | -7.24 |
Beta | 0.000 |
Volatility | 8.88% |
Current Volume | 15.4k |
Average Volume 20d | 7.7k |
Stop Loss | 592.5 (-3%) |
Signal | 1.09 |
What is the price of CSPX shares?
As of October 14, 2025, the stock is trading at EUR 610.86 with a total of 15,361 shares traded.
Over the past week, the price has changed by -0.07%, over one month by +2.38%, over three months by +7.62% and over the past year by +8.40%.
Over the past week, the price has changed by -0.07%, over one month by +2.38%, over three months by +7.62% and over the past year by +8.40%.
Is iShares Core SP500 USD EUR a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, iShares Core SP500 USD EUR (AS:CSPX) is currently (October 2025)
ok to buy, but has to be watched. It has a Growth Technical Rating of 53.61 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSPX is around 615.68 EUR . This means that CSPX is currently overvalued and has a potential downside of 0.79%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSPX is around 615.68 EUR . This means that CSPX is currently overvalued and has a potential downside of 0.79%.
Is CSPX a buy, sell or hold?
iShares Core SP500 USD EUR has no consensus analysts rating.
What are the forecasts/targets for the CSPX price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 689.5 | 12.9% |
CSPX Fundamental Data Overview
Market Cap USD = 153.95b (132.68b EUR * 1.1603 EUR.USD)
Market Cap EUR = 132.68b (132.68b EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 132.68b EUR (132.68b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 132.68b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 132.68b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.99% (E(132.68b)/V(132.68b) * Re(8.99%) + (debt-free company))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Market Cap EUR = 132.68b (132.68b EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 132.68b EUR (132.68b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 132.68b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 132.68b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.99% (E(132.68b)/V(132.68b) * Re(8.99%) + (debt-free company))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)